Deutsche Bank Ag\ Blueprint Medicines Corp Transaction History

Deutsche Bank Ag\

$245 Billion
Q1 2025

A detailed history of Deutsche Bank Ag\ transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Deutsche Bank Ag\ holds 199,937 shares of BPMC stock, worth $20.4 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

199,937

Previous 261,363 23.5%

Holding current value

$20.4 Million

Previous $22.8 Million 22.37%

% of portfolio

0.01%

Previous 0.01%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$86.69 - $115.63 $5.33 Million - $7.1 Million	-61,426 Reduced 23.5%	199,937 $17.7 Million
Q4 2024 Feb 14, 2025	BUY	$82.48 - $101.39 $1.85 Million - $2.27 Million	22,412 Added 9.38%	261,363 $22.8 Million
Q3 2024 Nov 13, 2024	BUY	$84.1 - $120.5 $1.59 Million - $2.28 Million	18,920 Added 8.6%	238,951 $22.1 Million
Q2 2024 Aug 14, 2024	BUY	$85.18 - $108.78 $7.97 Million - $10.2 Million	93,564 Added 73.98%	220,031 $23.7 Million
Q1 2024 May 15, 2024	SELL	$73.17 - $99.79 $1.2 Million - $1.63 Million	-16,368 Reduced 11.46%	126,467 $12 Million
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $2.65 Million - $5.6 Million	60,268 Added 72.99%	142,835 $13.2 Million
Q3 2023 Nov 09, 2023	BUY	$46.9 - $66.0 $178,454 - $251,130	3,805 Added 4.83%	82,567 $4.15 Million
Q2 2023 Aug 14, 2023	SELL	$42.2 - $66.37 $1.19 Million - $1.87 Million	-28,246 Reduced 26.4%	78,762 $4.98 Million
Q1 2023 May 15, 2023	BUY	$37.97 - $50.0 $827,404 - $1.09 Million	21,791 Added 25.57%	107,008 $4.81 Million
Q4 2022 Feb 13, 2023	SELL	$41.06 - $66.48 $4.11 Million - $6.66 Million	-100,195 Reduced 54.04%	85,217 $3.73 Million
Q3 2022 Nov 14, 2022	SELL	$49.93 - $77.7 $460,803 - $717,093	-9,229 Reduced 4.74%	185,412 $12.2 Million
Q2 2022 Aug 11, 2022	SELL	$45.23 - $70.15 $154,957 - $240,333	-3,426 Reduced 1.73%	194,641 $9.83 Million
Q1 2022 May 13, 2022	SELL	$54.1 - $110.08 $184,913 - $376,253	-3,418 Reduced 1.7%	198,067 $12.7 Million
Q4 2021 Feb 11, 2022	SELL	$94.25 - $115.99 $21.4 Million - $26.3 Million	-226,543 Reduced 52.93%	201,485 $21.6 Million
Q3 2021 Nov 04, 2021	SELL	$80.98 - $109.47 $312,582 - $422,554	-3,860 Reduced 0.89%	428,028 $44 Million
Q2 2021 Aug 11, 2021	BUY	$82.78 - $101.0 $5.12 Million - $6.25 Million	61,832 Added 16.71%	431,888 $38 Million
Q1 2021 May 13, 2021	SELL	$90.71 - $108.28 $4.83 Million - $5.77 Million	-53,295 Reduced 12.59%	370,056 $36 Million
Q4 2020 Feb 16, 2021	SELL	$92.08 - $124.48 $238,395 - $322,278	-2,589 Reduced 0.61%	423,351 $47.5 Million
Q3 2020 Nov 12, 2020	SELL	$66.45 - $92.7 $3.81 Million - $5.32 Million	-57,397 Reduced 11.88%	425,940 $39.5 Million
Q2 2020 Aug 13, 2020	BUY	$57.09 - $79.27 $7.56 Million - $10.5 Million	132,374 Added 37.72%	483,337 $37.7 Million
Q1 2020 May 14, 2020	BUY	$48.11 - $82.22 $2.67 Million - $4.57 Million	55,537 Added 18.8%	350,963 $20.5 Million
Q4 2019 Feb 14, 2020	SELL	$66.73 - $82.59 $447,224 - $553,518	-6,702 Reduced 2.22%	295,426 $23.7 Million
Q3 2019 Nov 14, 2019	SELL	$72.9 - $101.41 $640,207 - $890,582	-8,782 Reduced 2.82%	302,128 $22.2 Million
Q2 2019 Aug 14, 2019	BUY	$73.54 - $97.8 $10.9 Million - $14.6 Million	148,811 Added 91.8%	310,910 $29.3 Million
Q1 2019 May 15, 2019	BUY	$48.7 - $86.6 $640,015 - $1.14 Million	13,142 Added 8.82%	162,099 $13 Million
Q4 2018 Feb 14, 2019	SELL	$45.57 - $74.26 $2.92 Million - $4.75 Million	-64,010 Reduced 30.06%	148,957 $8.03 Million
Q3 2018 Dec 21, 2021	BUY	$58.91 - $78.32 $4.65 Million - $6.18 Million	78,967 Added 58.93%	212,967 $16.6 Million
Q3 2018 Nov 14, 2018	SELL	$58.91 - $78.32 $16.2 Million - $21.6 Million	-275,272 Reduced 67.26%	134,000 $10.5 Million
Q2 2018 Apr 21, 2020	BUY	$60.96 - $101.18 $1.75 Million - $2.9 Million	28,684 Added 7.54%	409,272 $26 Million
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $13.8 Million - $22.9 Million	226,466 Added 146.94%	380,588 $24.2 Million
Q1 2018 Oct 18, 2019	BUY	$73.28 - $102.95 $2.15 Million - $3.03 Million	29,392 Added 23.56%	154,122 $14.1 Million
Q1 2018 May 15, 2018	BUY	$73.28 - $102.95 $838,909 - $1.18 Million	11,448 Added 10.11%	124,730 $11.4 Million
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $3.59 Million - $5.04 Million	57,102 Added 101.64%	113,282 $8.54 Million
Q3 2017 Nov 14, 2017	BUY	$42.37 - $69.67 $2.38 Million - $3.91 Million	56,180	56,180 $3.91 Million

Others Institutions Holding BPMC

# of Institutions

394

Shares Held

60.4M

Call Options Held

1.6M

Put Options Held

1.41M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.08B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account